Injective’s INJ token jumped after the network brought onchain pre-IPO exposure for major private companies back into the market spotlight. Live market trackers showed INJ trading near $5.54 on CoinGecko, up about 18% over 24 hours, with market capitalization near $553 million and daily trading volume above $300 million.
That move added tens of millions of dollars to INJ’s market value as traders reacted to Injective’s post that onchain pre-IPO stocks for OpenAI, SpaceX and Anthropic are live. The rally also came as INJ outperformed the broader crypto market, with CoinGecko showing a 43.9% seven-day gain while the global market was nearly flat over the same window.
The launch builds on Injective’s earlier rollout of onchain pre-IPO perpetual futures, which let users trade price exposure to private companies including OpenAI, SpaceX, Anthropic and Perplexity with up to 5x leverage. These products are designed as derivatives tied to private-market reference prices, not direct company shares, IPO allocations, voting rights or ownership in the underlying businesses.
That distinction is important. Pre-IPO markets can give crypto traders exposure to private-company valuation moves, but they also introduce risks around pricing sources, liquidity, leverage, settlement terms and jurisdictional access. A tokenized or perpetual product linked to a private company is not the same as holding equity on a cap table.
Tokenized Private Markets Become A Bigger RWA Trade
The INJ rally fits a broader market rotation into tokenized real-world assets and onchain equities. Recent tokenized-stock expansion across other ecosystems, including Securitize, Jump and Jupiter bringing tokenized equities trading to Solana, has made private and public equity exposure one of the most competitive RWA themes in crypto.
Injective’s angle is different because it is focused on financial-chain infrastructure and derivatives rather than simple wrapped equity tokens. TradingView-linked Cointelegraph coverage said the pre-IPO perpetuals use onchain data from Seda Protocol and private-market pricing from Caplight, with the first market built around OpenAI and additional private-company markets planned.
The demand case is clear. Companies such as OpenAI, SpaceX and Anthropic remain difficult for ordinary investors to access before an IPO, while crypto-native traders are already comfortable using perpetual futures to price volatile assets. Bringing that format to private-company exposure gives Injective a sharper story around onchain markets, RWAs and programmable finance.
The risk is that valuation excitement can move faster than market depth. Private-company pricing is less transparent than public equities, and leveraged exposure can amplify both upside and downside if liquidity thins. INJ’s latest move shows that traders are rewarding the narrative, but the next test is whether those pre-IPO markets generate durable volume, collateral demand and fee activity beyond the first wave of launch-driven speculation.
